Quantifying the Impact of Chronic Obstructive Sialadenitis on Quality of Life
<b>Objectives</b>: To evaluate the loss of quality of life (QoL) in patients with chronic obstructive sialadenitis (COS) using the Chronic Obstructive Sialadenitis Questionnaire (COSQ). <b>Methods</b>: The COSQ was administered to patients diagnosed with COS, with the diagnosis confirmed by sialendoscopy. Epidemiological data, obstructive causes and potentially obstructive entities were collected. QoL was assessed using the COSQ. <b>Results</b>: A total of 344 glands in 278 patients with COS were analyzed. Most patients were women (71.94%), and the main obstructive cause was stenosis (47.96%), followed by lithiasis, lack of papilla distensibility (LPD), and mucus plug. Stenosis was significantly more frequent in the parotid gland and in women, whereas lithiasis predominated in the submandibular gland and in men. The mean COSQ score was 30.55 and it was significantly higher in women (<i>p</i> < 0.005), parotid gland (<i>p</i> < 0.005), and in long-standing cases (<i>p</i> < 0.05). Stenosis and LPD were the obstructive causes with the greatest impact on QoL (<i>p</i> < 0.005), while lithiasis had the least impact. Potentially Obstructive Entities (POEs), such as eosinophilic sialodochitis, Sjögren's syndrome, or radioiodine-induced sialadenitis, were associated with a notable loss of QoL. Likewise, patients without associated POEs presented significantly lower COSQ values (<i>p</i> < 0.05). <b>Conclusions</b>: COS significantly affects QoL, particularly in women and in cases of parotid gland, stenosis, and LPD. Lithiasis has the least impact on QoL. It is important to standardize a thorough evaluation of COS using validated tools such as the COSQ, which are fundamental for understanding the disease and predicting the outcomes of therapeutic interventions.
Authors
- Ignacio Mahíllo (ORCID: https://orcid.org/0000-0003-0558-6541)
- Carlos Cenjor Español (ORCID: https://orcid.org/0000-0002-2595-7058)
- Alberto Valentín González (ORCID: https://orcid.org/0009-0009-0425-989X)
- William Aragonés Sanzen-Baker (ORCID: https://orcid.org/0000-0002-8481-679X)
- Philip C. Marin
- Ignacio Alcalá Rueda (ORCID: https://orcid.org/0000-0003-3309-187X)
- Jessica Mireya Santillán Coello (ORCID: https://orcid.org/0000-0003-2519-1993)
- José Miguel Villacampa Aubá (ORCID: https://orcid.org/0000-0002-1321-007X)
- Gonzalo Díaz Tapia (ORCID: https://orcid.org/0000-0003-3589-1379)
- Álvaro Sánchez Barrueco (ORCID: https://orcid.org/0000-0002-7919-5765)
Institutions
- Consejo Superior de Investigaciones Científicas (ES)
- Hospital Universitario Fundación Jiménez Díaz (ES)
- Universidad Alfonso X el Sabio (ES)
- Universidad Autónoma de Madrid (ES)
Publication Details
- Journal
- Journal of Clinical Medicine
- Published
- 2025-10-24
- DOI
- https://doi.org/10.3390/jcm14217560
- Primary Topic
- Salivary Gland Tumors Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00